TCF12 Polyclonal Antibody
BS-11237R
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetTCF12
Overview
- SupplierBioss
- Product NameTCF12 Polyclonal Antibody
- Delivery Days Customer16
- ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
- Applications SupplierWB(1:300-5000), ELISA(1:500-1000), IHC-P(1:200-400), IHC-F(1:100-500), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 ug/ul
- ConjugateUnconjugated
- Gene ID6938
- Target nameTCF12
- Target descriptiontranscription factor 12
- Target synonymsCRS3, HEB, HH26, HTF4, HsT17266, TCF-12, bHLHb20, p64, transcription factor 12, DNA-binding protein HTF4, E-box-binding protein, class B basic helix-loop-helix protein 20, helix-loop-helix transcription factor 4, transcription factor HTF-4
- HostRabbit
- IsotypeIgG
- Protein IDQ99081
- Protein NameTranscription factor 12
- Storage Instruction-20°C
- UNSPSC12352203
References
- Chen QB, Liang YK, Zhang YQ, et al. Decreased expression of TCF12 contributes to progression and predicts biochemical recurrence in patients with prostate cancer. Tumour Biol. 2017,39(6):1010428317703924. doi: 10.1177/1010428317703924Read this paper





